Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

John M Timmerman

Showing results (11-20 of 60) with videos related to

Pageof 6
Sort By:
Proceedings of the National Academy of Sciences of the United States of America|September 10, 2003
Extending the utility of gene profiling data by bridging microarray platformsGregory Z Ferl, John M Timmerman, Owen N Witte
Journal of the National Cancer Institute|April 3, 2003
Antitumor immunity after vaccination with B lymphoma cells overexpressing a triad of costimulatory moleculesJavier Briones, John M Timmerman, Dennis L Panicalli, et al.
Experimental Hematology|February 2, 2002
BLyS and BLyS receptor expression in non-Hodgkin's lymphomaJavier Briones, John M Timmerman, David M Hilbert, et al.
Trends in Immunology|January 28, 2003
Determinant spreading and tumor responses after peptide-based cancer immunotherapyAntoni Ribas, John M Timmerman, Lisa H Butterfield, et al.
Blood|February 9, 2010
Targeted delivery of interferon-alpha via fusion to anti-CD20 results in potent antitumor activity against B-cell lymphomaCaiyun Xuan, Kristopher K Steward, John M Timmerman, et al.
Journal of Immunology (Baltimore, Md. : 1950)|September 5, 2008
Sulfhydryl-based tumor antigen-carrier protein conjugates stimulate superior antitumor immunity against B cell lymphomasDavid J Betting, Kamran Kafi, Alireza Abdollahi-Fard, et al.
Molecular Immunology|December 3, 2008
Maleimide conjugation markedly enhances the immunogenicity of both human and murine idiotype-KLH vaccinesKamran Kafi, David J Betting, Reiko E Yamada, et al.
Mabs|July 1, 2016
Targeted immunotherapy using anti-CD138-interferon α fusion proteins and bortezomib results in synergistic protection against multiple myelomaAlex Vasuthasawat, Esther M Yoo, Kham R Trinh, et al.
Journal of Immunotherapy (Hagerstown, Md. : 1997)|June 2, 2009
Intratumoral but not systemic delivery of CpG oligodeoxynucleotide augments the efficacy of anti-CD20 monoclonal antibody therapy against B cell lymphomaDavid J Betting, Reiko E Yamada, Kamran Kafi, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|September 21, 2017
ImmunoPET of Malignant and Normal B Cells with <sup>89</sup>Zr- and <sup>124</sup>I-Labeled Obinutuzumab Antibody Fragments Reveals Differential CD20 Internalization <i>In Vivo</i>Kirstin A Zettlitz, Richard Tavaré, Scott M Knowles, et al.
Pageof 6

Showing results (11-20 of 60) with videos related to

Sort By:
Pageof 6
Proceedings of the National Academy of Sciences of the United States of America|September 10, 2003
Extending the utility of gene profiling data by bridging microarray platformsGregory Z Ferl, John M Timmerman, Owen N Witte
Journal of the National Cancer Institute|April 3, 2003
Antitumor immunity after vaccination with B lymphoma cells overexpressing a triad of costimulatory moleculesJavier Briones, John M Timmerman, Dennis L Panicalli, et al.
Experimental Hematology|February 2, 2002
BLyS and BLyS receptor expression in non-Hodgkin's lymphomaJavier Briones, John M Timmerman, David M Hilbert, et al.
Trends in Immunology|January 28, 2003
Determinant spreading and tumor responses after peptide-based cancer immunotherapyAntoni Ribas, John M Timmerman, Lisa H Butterfield, et al.
Blood|February 9, 2010
Targeted delivery of interferon-alpha via fusion to anti-CD20 results in potent antitumor activity against B-cell lymphomaCaiyun Xuan, Kristopher K Steward, John M Timmerman, et al.
Journal of Immunology (Baltimore, Md. : 1950)|September 5, 2008
Sulfhydryl-based tumor antigen-carrier protein conjugates stimulate superior antitumor immunity against B cell lymphomasDavid J Betting, Kamran Kafi, Alireza Abdollahi-Fard, et al.
Molecular Immunology|December 3, 2008
Maleimide conjugation markedly enhances the immunogenicity of both human and murine idiotype-KLH vaccinesKamran Kafi, David J Betting, Reiko E Yamada, et al.
Mabs|July 1, 2016
Targeted immunotherapy using anti-CD138-interferon α fusion proteins and bortezomib results in synergistic protection against multiple myelomaAlex Vasuthasawat, Esther M Yoo, Kham R Trinh, et al.
Journal of Immunotherapy (Hagerstown, Md. : 1997)|June 2, 2009
Intratumoral but not systemic delivery of CpG oligodeoxynucleotide augments the efficacy of anti-CD20 monoclonal antibody therapy against B cell lymphomaDavid J Betting, Reiko E Yamada, Kamran Kafi, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|September 21, 2017
ImmunoPET of Malignant and Normal B Cells with <sup>89</sup>Zr- and <sup>124</sup>I-Labeled Obinutuzumab Antibody Fragments Reveals Differential CD20 Internalization <i>In Vivo</i>Kirstin A Zettlitz, Richard Tavaré, Scott M Knowles, et al.
Pageof 6